Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Precancerous Conditions × Other neoplasm × Clear all

Phase

Phase 2 42 Phase NA 31 Phase 3 28 Phase 1 26 Phase 1/2 7 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Dermatologic 1

Conditions

TP53 1 Primary Malignant Neoplasm of Ovary 1 Precancerous Conditions 1 Older Patients 1 Keratosis, Actinic 1 Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

University of Alabama at Birmingham

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡